Targeting the α7 nicotinic acetylcholine receptor to prevent progressive dementia and improve cognition in adults with Down's syndrome-Reference-Cited by-同舟云学术

Targeting the α7 nicotinic acetylcholine receptor to prevent progressive dementia and improve cognition in adults with Down's syndrome

Published:2014-10 Issue: Volume:54 Page:131-139
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Deutsch Stephen I.,Burket Jessica A.,Benson Andrew D.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference34 articles.

1. Schizophrenia, sensory gating, and nicotine receptors;Adler;Schizophr Bull,1998

2. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function;Albuquerque;J Pharmacol Exp Ther,1997

3. Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of α7 receptors;Albuquerque;J Physiol Paris,1998

4. Choline is a selective agonist of α7 nicotinic acetylcholine receptors in the rat brain neurons;Alkondon;Eur J Neurosci,1997

5. Selective α7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3β and decreases tau phosphorylation in vivo;Bitner;Brain Res,2009

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating the catalytic activities of nanozymes for molecular sensing;Nano Today;2024-06

2. A Systematic Review on Drugs Acting as Nicotinic Acetylcholine Receptor Agonists in the Treatment of Dementia;Cells;2024-01-26

3. Total synthesis of the natural (−)-205B alkaloid and its activity toward α7 nAChRs;Organic & Biomolecular Chemistry;2023

4. Mesenchymal stem cell application for treatment of neuroinflammation-induced cognitive impairment in mice;Regenerative Medicine;2022-08

5. The Human-Restricted Isoform of the α7 nAChR, CHRFAM7A: A Double-Edged Sword in Neurological and Inflammatory Disorders;International Journal of Molecular Sciences;2022-03-22